BNurs, MPH, MPhil, PhD, RN, FAAN, APN(Education and Research in Nursing)
Director, Doctor of Nursing Programme
Prof Kelvin Wang is Professor at the School of Nursing of the University of Hong Kong. Prof. Wang received his BN, MPH, MPhil and PhD from the University of Hong Kong. He is Fellow of American Academy of Nursing (FAAN), Co-leader of Smoking Cessation & Tobacco Control team (HKU), Principal investigator of Hong Kong Jockey Club Smart Family Link Project (Phase 2, Nursing), Associate Editor of BMC Public Health and editorial board member of Scientific Reports, Frontiers in Psychology (Health Psychology) and the MHealth, and Council member of Hong Kong Council on Smoking & Health.
He has published more than 190 papers (e.g. JAMA Internal Medicine, Lancet Digital Health, Addiction, Tobacco Control, etc.) (Google Scholar H-index: 31) and awarded Faculty Outstanding Research Output 2022. His research focuses on behavioral intervention, addiction, policy evaluation, and health communication. He led the team on alternative tobacco products (ATPs) research has been awarded Faculty Knowledge Exchange Award 2022 for the impactful research on total ban of ATPs. The Community-based Smoking Cessation Program has been awarded American Academy of Nursing Edge Runner as an excellent nursing model.
Kelvin is a randomista and particularly interested in complex trial design, personalised intervention, advanced statistical analysis, sustainability and scalability of new interventions. More information please visit HKU Smoking Cessation Research lab: https://sctc.nursing.hku.hk/.
|Funding Scheme||Project Title||Approved Amount (HK$)|
|RGC General Research Fund (GRF)||Nurse-led post-discharge cessation support for smoking patients using mobile-based intervention: a randomized controlled trial||1,173,722|
|RGC General Research Fund (GRF)||Nurse-led alcohol brief intervention plus mobile personalized chat-based support on reducing alcohol use in university students: a pragmatic randomized controlled trial.||1,180,742|
|Health and Medical Research Fund||Alcohol brief intervention integrated with mobile chat-based support for risky drinkers in emergency departments: a pragmatic randomised controlled trial||981,995|
|RGC General Research Fund (GRF)||Personalized support using instant messaging applications to increase smoking cessation in smokers proactively recruited from smoking hotspots in Hong Kong: a pragmatic randomized controlled trial||581,565|
|HMRF Research Fellowship Scheme||Intervention combining interactive communication technologies and nicotine replacement therapy sampling for proactively recruited smokers in smoking hotspots: a pragmatic randomized controlled trial||1,070,555|
|Health and Medical Research Fund||A combined cessation intervention with brief advice, nicotine replacement therapy sampling and active referral (BANSAR) for smoking fathers: a multicenter, single-blinded, pragmatic randomized controlled trial||999,870|
- Council Member of Hong Kong Council on Smoking and Health
- Member of the Society for Nicotine & Tobacco Research
- Member of the Pi Iota Chapter, Sigma Theta Tau Honor Society of Nursing
- Member of Hong Kong College of Nursing
- Member of Society of Behavioral Medicine
- Member of International Behavioral Trials Network
- Health and Medical Research Fund, Grant Review Board, Food & Health Bureau
- Co-opted Member of the Registration Committee, Nursing Council of Hong Kong
- Governing Committee Member of HK NT West & HK Island South District Health Centres
- Luk TT, Lam TH, Leung WC, Leung KY, Cheung KW, Kwa C, Siong KH, Tang KK, Lee KW, Hsieh CJ, Wu Y, Li WHC and Wang MP*, Brief advice, nicotine replacement therapy sampling, and active referral for expectant fathers who smoke cigarettes: a randomized clinical trial. JAMA Internal Medicine 2021;181(8):1081-1089. (2020 IF = 21.873. Ranking = 8/169 in Medicine, General & Internal, SCIE)
- Weng X, Wu Y, Luk TT, Li WHC, Cheung YTD, Tong HSC, Lai VWY, Lam TH and Wang MP*, Active referral plus a small financial incentive upon cessation services use on smoking abstinence: a community-based, cluster-randomised controlled trial. The Lancet Regional Health - Western Pacific. 2021, 13, 100189.
- Wang L, Chen J, Leung LT, Mai Z, Ho DSY, Lam TH and Wang MP, Characterization of respiratory symptoms among youth using heated tobacco products in Hong Kong, JAMA Network Open. 2021;4(7), e2117055. 17055 (2020 IF=8.483; Ranking = 15/169 in Medicine, General & Internal, SCIE)
- Li WHC, Ho KY, Wang MP, Cheung YTD, Lam KWK, Xia W, Cheung KY, Wong CKH, Chan SSC and Lam TH, Effectiveness of a brief self-determination theory-based smoking cessation intervention for smokers at emergency departments in Hong Kong: a randomised controlled trial, JAMA Internal Medicine. 2019;180(2), 206-214. (2020 IF = 21.873. Ranking = 8/169 in Medicine, General & Internal, SCIE)
- Wang MP*, Luk TT, Wu Y, Li WH, Cheung DY, Kwong AC, Lai V, Chan SS, Lam TH. Chat-based instant messaging support integrated with brief interventions for smoking cessation: a community-based, pragmatic, cluster-randomised controlled trial. The Lancet Digital Health. 2019 Aug;1(4):e183-92. (2020 IF = 24.519. Ranking = 1/30 in Medical Informatics, 7/169 in Medicine, General & Internal, SCIE)
- Wang MP*, Suen YN, Li WH, Lam CO, Yong-da Wu S, Kwong AC, Lai VW, Chan SS, Lam TH. Intervention with brief cessation advice plus active referral for proactively recruited community smokers: a pragmatic cluster randomized clinical trial. JAMA Internal Medicine. 2017 Dec;177(12):1790-7. (2020 IF = 21.873. Ranking = 8/169 in Medicine, General & Internal, SCIE)
- Wang MP, Ho SY, Leung LT, Lam TH. Electronic cigarette use and respiratory symptoms in Chinese adolescents in Hong Kong. JAMA Pediatrics. 2016 Jan;170(1):89-91. (2020 IF = 16.193. Ranking = 1/129 in Pediatrics, SCIE)